Search

everythinglearnresearchcommunity

for

Search:↓

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

The scaffold with polydopamine and bioactive glass effectively promotes bone regeneration.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Certain Dibenzo derivatives may help treat prostate cancer.

CaBP1 and 2 are necessary for maintaining calcium currents and hearing in inner ear cells.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

TBX3 gene affects horse coat color, with higher expression in darker areas.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib helps treat severe hair loss in people over 65.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

The dog has Color Dilution Alopecia, causing hair loss and increased risk of skin infections.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

The document corrected previous errors and announced future dermatology events.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.